Skip to main content

Advertisement

Log in

Gastric Electrical Stimulation and Sacral Electrical Stimulation: A Long-Term Follow-Up Study of Dual-Device Treatment

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Aims

The objective of this study was to investigate sacral electrical stimulation (SES) and gastric electrical stimulation (GES) by comparing upper and lower gastrointestinal (GI) and genitourinary (GU) symptoms and quality of life, before treatment and in the long term after treatment. We hypothesized that dual-device treatment would greatly improve upper and lower gastrointestinal and genitourinary symptoms, as well as quality of life.

Methods

Fifty-four patients who underwent dual-device treatment (GES and SES) were enrolled in this study. Patients who had surpassed 24 months since the second-device insertion were included. Patients were evaluated before and after both devices were implanted and given a symptom questionnaire regarding their upper GI, lower GI, and GU symptoms and their quality of life.

Results

With combined treatment, a statistically significant improvement was seen in upper GI, lower GI, and GU symptoms and quality of life. However, fecal incontinence and fecal urgency improvements did not reach statistical significance, likely due to the small sample size.

Conclusion

The implantation of two stimulators appears to be safe and effective to improve patients’ quality of life for those with upper GI symptoms, bowel problems, and bladder dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18–37.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Creel WB, Abell L, Lobranao A, et al. To clot or not to clot: are there predictors of clinically significant thrombus formation in patients with gastroparesis and prolonged IV access? Dig Dis Sci. 2008;3:1532–1536.

    Article  Google Scholar 

  3. Lahr CJ, Griffith J, Subamony C, Halley L. Gastric electrical stimulation for abdominal pain in patients with symptoms of gastroparesis. Am Surg.. 2013;79:457–464.

    PubMed  Google Scholar 

  4. Bonapace ES, Davido S, Krevesky B, Fisher RS, Parkman HP. Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J. Gastroenterol. 2000;95:2838–2847.

    Article  PubMed  CAS  Google Scholar 

  5. Caballeo-Plasencia AM, Valenzulea-Barranco M, Herrias-Gutierrez JM, Esteban-Carretero JM. Altered gastric emptying in patients with irritable bowel syndrome. Eur J Nucl Med. 1999;26:404–409.

    Article  Google Scholar 

  6. Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol. 1993;34:48–54.

    Article  Google Scholar 

  7. Farup CE, Williams GR, Leidy NK, Helbers L, Mura M, Quigley EMM. Effect of domperidone on the health related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care. 1998;21:1699–1706.

    Article  PubMed  CAS  Google Scholar 

  8. Medtronics. What is a humanitarian device? 2015. Available from: http://www.medtronic.com/patients/gastroparesis/device/what-is-it/.

  9. Abell TL. Gastric electric stimulation is a viable option in gastroparesis treatment. Nat Clin Pract Gastroenterol Hepatol. 2009;6:E8–E13.

    Article  PubMed  Google Scholar 

  10. O’Grady G, Egbuji JU, Du P, et al. High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World J Surg. 2009;33:693–1701.

    Google Scholar 

  11. Leroi AM, Parc Y, Lehur PA. Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Ann Surg. 2005;242:662–669.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Van Kerebroeck PE, Van Voskuilen A, Cheesakkers JP. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178:2029–2034.

    Article  Google Scholar 

  13. Kohli N, Patteson D. Interstim® therapy: a contemporary approach to overactive bladder. Rev Obstet Gynecol. 2009;2:18–27.

    PubMed  PubMed Central  Google Scholar 

  14. Cutts TF, Luo J, Starkebaum W, Rashed H, Abell TL. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil.. 2005;17:35–43.

    Article  PubMed  CAS  Google Scholar 

  15. Carrington EV, Evers J, Grossi U, et al. A systematic review of sacral nerve stimulation mechanisms in the treatment of fecal incontinence and constipation. Neurogastroenterol Motil. 2014;26:1222–1237.

    Article  PubMed  CAS  Google Scholar 

  16. Wald Arnold. New treatments for fecal incontinence: update for the gastroenterologist. Clin Gastroenterol Hepatol. 2014;12:1783–1788.

    Article  PubMed  Google Scholar 

  17. Patton V, Wiklendt L, Arkwright JW, et al. The effect of sacral neve stimulation on distal colonic motility in patients with faecal incontinence. Br J Surg. 2013;100:959–968.

    Article  PubMed  CAS  Google Scholar 

  18. Zhang J, Chen JD. Systematic review: application and future of gastric electrical stimulation. Aliment Pharmacol Ther. 2006;24:991–1002.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge the following people for their contribution to this study: Paige White, MD, Roger Dmochowski, MD, William Duncan, MD, Charles L Secrest, MD, John Brizzolara, MD, Howard Goldman, MD, Amar Al-Juburi, MD, Danielle Spree FNP, and Catherine McBride.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas L. Abell.

Ethics declarations

Conflict of interest

Dr. Abell has been a consultant, investigator, and licensor to Medtronic.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 12 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agrawal, A., Francis, S.L., Deveneau, N.E. et al. Gastric Electrical Stimulation and Sacral Electrical Stimulation: A Long-Term Follow-Up Study of Dual-Device Treatment. Dig Dis Sci 61, 176–180 (2016). https://doi.org/10.1007/s10620-015-3840-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3840-4

Keywords

Navigation